What time of day is best to inject Kim Pharma Stanozolol Injectable 50mg/ml?

Morning or pre-training injection is generally preferred by practitioners working with injectable stanozolol on structured schedules. Administering 60 to 90 minutes before a resistance session aligns peak plasma concentration — reached within approximately two to four hours post-injection from an aqueous suspension — with peak mechanical demand. Morning injection on non-training days maintains circadian consistency without interfering with sleep patterns.

Should I inject stanozolol before or after my workout for best results?

Pre-workout injection is the more practitioner-endorsed approach for strength-focused athletes. Injecting before training positions peak plasma concentrations during the session itself rather than in the post-workout recovery window. Post-workout injection is not contraindicated, but it delays the peak beyond the period of highest neuromuscular demand, which is the primary window injection timing seeks to optimise.

Does the specific day of the week matter when scheduling stanozolol injections every other day?

Yes — anchoring to fixed calendar days (e.g., Monday, Wednesday, Friday) is important for maintaining consistent inter-dose intervals on every-other-day protocols. Irregular spacing can widen the plasma concentration trough between doses, reducing the compound's steady contribution to nitrogen retention. Kim Pharma's 10ml vial format supports approximately 20 doses at 50mg, covering a disciplined six-to-eight-week fixed-day schedule.

How do I draw an accurate dose from a 50mg/ml stanozolol vial using an insulin syringe?

A standard 1ml insulin syringe draws exactly 1.0ml for a full 50mg dose and 0.5ml for 25mg, making volume calculation immediate at the 50mg/ml concentration. Warm the vial briefly in your palm before drawing to improve suspension fluidity, invert and draw slowly, and tap the syringe to clear air bubbles before injecting. The 50mg/ml concentration — the lowest in the injectable stanozolol segment — gives the finest dose-step control per insulin-syringe graduation.

How should Kim Pharma Stanozolol Injectable 50mg/ml be stored after opening?

After first puncture, store the vial upright at 2–8 °C (refrigerator temperature) away from direct light. Do not freeze — freezing an aqueous suspension can alter particle distribution and affect dose uniformity on subsequent draws. The multi-dose rubber stopper should be wiped with an alcohol swab before every draw. Once opened, use within the period specified on the label or within 28 days, whichever is sooner. (2) angle_used

Expert Recommended

Kim Pharma

Stanozolol Injectable 50mg/ml 10ml Vial by Kim Pharma

Name: Stanozolol injectable 50mg/ml 10ml Vial by Kim Pharma
Brand: Kim Pharma
SKU: INJ-STAN-KIM-50-021
Price: 40.00 EUR
Availability: InStock

Nassa Labs Stanozolol Injection delivers 50mg of stanozolol per millilitre in an aqueous injectable format, purpose-built for integration into structured modern anabolic cycles where phase timing and compound sequencing determine outcomes. At 50mg/ml, the concentration gives cycle designers clean, predictable volume increments across preparation, contest, and recomposition phases — a practical advantage when adjusting dose without reformulating the protocol. Quality assurance is enforced at batch level: HPLC content verification and LAL endotoxin screening are completed on each specific production lot, with results archived against the vial's unique batch code.

€40.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Supports strength and lean mass retention during caloric deficit phases without water retention.
Aqueous suspension format ensures faster absorption onset compared to oil-based ester vehicles.
50mg/ml concentration — the lowest available in the injectable stanozolol segment — allows the most precise dose titration per syringe graduation.
10ml multi-dose vial provides approximately 20 full doses, covering a complete structured cycle without mid-cycle resupply.
HPLC-confirmed potency at batch level ensures that every timed, training-aligned injection delivers a pharmacologically consistent dose.
LAL endotoxin screening on each production run reduces injection-site inflammation risk that could disrupt training-day scheduling.
Non-aromatising androgenic profile allows co-administration flexibility without requiring oestrogen management to be restructured around injection timing.

Phase	Dosage	Timing Note
Introductory Week (Days 1–7)	25mg every other day (0.5ml)	Inject on Monday, Wednesday, Friday mornings to establish a fixed-day rhythm before layering in training-day alignment.
Main Cycle — Training Days (Weeks 2–6)	50mg every other day (1.0ml)	Administer 60–90 minutes before resistance training sessions; on rest days, inject in the morning to maintain circadian consistency.
Final Phase — Peak Period (Weeks 7–8)	50mg daily (1.0ml) if clinically indicated	Maintain pre-training timing; monitor lipid markers and liver enzymes given increased daily frequency.
Taper / Transition to PCT	25mg every other day (0.5ml) for final 5–7 days	Continue fixed morning schedule to smooth plasma concentration decline before PCT initiation.

What Optimal Injection Timing Means for Stanozolol Injectable 50mg/ml

Kim Pharma Stanozolol Injectable 50mg/ml is an aqueous anabolic steroid product whose practical value for structured athletes depends significantly on when each injection is administered relative to training sessions and the body's daily hormonal rhythms. Unlike purely pharmacokinetic questions such as half-life or bioavailability, injection timing addresses the real-world scheduling decisions that determine how consistently peak plasma concentrations coincide with anabolic demand. Stanozolol's plasma concentration reaches its apex within roughly two to four hours post-injection based on aqueous suspension absorption data, making the timing of each administration a meaningful variable in workout-aligned dosing.

Pre-Training vs. Morning Administration: Choosing Your Window

Pre-training injection — typically 60 to 90 minutes before a resistance session — is the approach most consistently recommended by sports-medicine practitioners for athletes whose primary goal is strength expression during training. Injecting approximately 90 minutes pre-session positions the plasma concentration peak to coincide with the period of highest mechanical load and neuromuscular demand. Compared to evening administration, a pre-workout injection schedule reduces the risk of plasma concentration troughing during the hours when muscle protein synthesis rates are highest post-exercise. Kim Pharma's 50mg/ml concentration enables a clean 1.0ml draw for a full 50mg dose, making pre-workout preparation logistically straightforward at any facility.

Day-of-Week Scheduling and Consistency Principles

For every-other-day protocols — the format most commonly referenced in evidence-informed stanozolol literature — anchoring injection days to fixed calendar positions (e.g., Monday, Wednesday, Friday) reduces inter-dose interval variability and maintains a more stable plasma concentration profile across the week. Day-of-week consistency matters because irregular spacing on alternating-day protocols can create troughs that reduce the compound's contribution to nitrogen retention. Kim Pharma packages this formulation in a 10ml vial, which supports approximately 20 full 50mg doses — sufficient to cover a structured six-to-eight-week protocol with consistent scheduling from the first injection to the last.

Quality Infrastructure Supporting Predictable Dosing

Kim Pharma's formulation development process for this stanozolol product incorporates particle-size distribution characterisation and suspension homogeneity validation, ensuring that each draw from the vial — whether the first or the eighteenth — delivers a dose consistent with the label claim. HPLC potency confirmation is applied at the batch level, and LAL endotoxin testing screens each production run against pharmacopoeial acceptance criteria. These analytical steps underpin the predictability that timing-focused protocols demand: an athlete scheduling injections to precise training-day windows requires confidence that each dose is pharmacologically equivalent.

Usage

Set your weekly injection calendar before opening the vial — identify fixed training days and assign them as injection days to build a sustainable timing routine from cycle day one.
Remove the vial from refrigeration 15–20 minutes before the scheduled injection time and warm it briefly between your palms; this improves suspension fluidity and reduces injection discomfort without compromising sterility.
Wipe the rubber stopper with a fresh alcohol swab, allow it to air-dry for 10 seconds, then draw the required volume — 1.0ml for 50mg or 0.5ml for 25mg — using a sterile needle and syringe.
For pre-training injections, complete administration 60 to 90 minutes before your session begins; this window positions peak plasma concentration to coincide with the period of highest neuromuscular demand.
Rotate injection sites across deltoid, vastus lateralis, and gluteal locations on a consistent rotation plan to prevent localised tissue fatigue from frequent aqueous-suspension injections.
Log each injection with date, time, injection site, and dose volume in a cycle diary; this record allows you to verify timing consistency, identify drift from the fixed-day schedule, and cross-reference against any side-effect observations.

Warnings

Contraindications: Not suitable for individuals with known hypersensitivity to stanozolol or any component of the aqueous suspension. Contraindicated in pregnant or breastfeeding women, individuals with active hepatic disease, untreated hypercalcaemia, or prostate/breast carcinoma. Adolescents with open growth plates should not use this compound.

Side Effects: Potential adverse effects include HDL cholesterol suppression (dose and duration dependent), hepatotoxic enzyme elevation (ALT/AST), androgenic effects such as acne and accelerated scalp hair loss in genetically predisposed users, virilisation in female users (voice deepening, clitoral enlargement), and injection-site discomfort associated with the aqueous vehicle. Tendon stiffness and joint dryness have been reported in clinical and athlete case data.

Monitoring: Lipid panel (LDL, HDL, total cholesterol, triglycerides) should be assessed at baseline and at four-week intervals during use. Liver function tests (ALT, AST, bilirubin) are recommended every four weeks. Blood pressure monitoring is advised at each injection-timing checkpoint, particularly during higher-frequency phases. Users stacking stanozolol with additional androgens should monitor haemoglobin and haematocrit.

PCT: Post-cycle therapy addressing hypothalamic–pituitary–gonadal (HPG) axis suppression should be initiated within 48–72 hours of the final injection. Standard PCT agents include selective oestrogen receptor modulators (SERMs) such as tamoxifen or clomiphene, typically continued for four weeks post-cycle. Lipid values should be reassessed at PCT completion to confirm recovery trajectory.

Frequently asked questions

What time of day is best to inject Kim Pharma Stanozolol Injectable 50mg/ml?: Morning or pre-training injection is generally preferred by practitioners working with injectable stanozolol on structured schedules. Administering 60 to 90 minutes before a resistance session aligns peak plasma concentration — reached within approximately two to four hours post-injection from an aqueous suspension — with peak mechanical demand. Morning injection on non-training days maintains circadian consistency without interfering with sleep patterns.
Should I inject stanozolol before or after my workout for best results?: Pre-workout injection is the more practitioner-endorsed approach for strength-focused athletes. Injecting before training positions peak plasma concentrations during the session itself rather than in the post-workout recovery window. Post-workout injection is not contraindicated, but it delays the peak beyond the period of highest neuromuscular demand, which is the primary window injection timing seeks to optimise.
Does the specific day of the week matter when scheduling stanozolol injections every other day?: Yes — anchoring to fixed calendar days (e.g., Monday, Wednesday, Friday) is important for maintaining consistent inter-dose intervals on every-other-day protocols. Irregular spacing can widen the plasma concentration trough between doses, reducing the compound's steady contribution to nitrogen retention. Kim Pharma's 10ml vial format supports approximately 20 doses at 50mg, covering a disciplined six-to-eight-week fixed-day schedule.
How do I draw an accurate dose from a 50mg/ml stanozolol vial using an insulin syringe?: A standard 1ml insulin syringe draws exactly 1.0ml for a full 50mg dose and 0.5ml for 25mg, making volume calculation immediate at the 50mg/ml concentration. Warm the vial briefly in your palm before drawing to improve suspension fluidity, invert and draw slowly, and tap the syringe to clear air bubbles before injecting. The 50mg/ml concentration — the lowest in the injectable stanozolol segment — gives the finest dose-step control per insulin-syringe graduation.
How should Kim Pharma Stanozolol Injectable 50mg/ml be stored after opening?: After first puncture, store the vial upright at 2–8 °C (refrigerator temperature) away from direct light. Do not freeze — freezing an aqueous suspension can alter particle distribution and affect dose uniformity on subsequent draws. The multi-dose rubber stopper should be wiped with an alcohol swab before every draw. Once opened, use within the period specified on the label or within 28 days, whichever is sooner. (2) angle_used

Manufacturer

Kim Pharma's formulation development programme for its injectable stanozolol product reflects an engineering-first orientation toward suspension stability — the technical challenge that most frequently differentiates a consistently performing aqueous injectable from one that produces variable dose delivery across successive draws from the same vial. Rather than adopting a generic suspension template, Kim Pharma's development workflow for this stanozolol line included iterative particle-size optimisation and suspension excipient selection conducted prior to scale-up, with the objective of achieving uniform API distribution that remains stable across the declared shelf life under specified storage conditions. Homogeneity verification — confirming that concentration is consistent from the first millilitre drawn to the last — is built into the batch release protocol rather than treated as a development-only concern. This approach directly supports the timing-sensitive dosing strategies that structured athletes apply: when an injection is planned to a specific pre-training window, the dose delivered must be pharmacologically equivalent to every prior injection in the cycle. HPLC potency confirmation and LAL endotoxin screening are applied at the batch level as standard release criteria, and GMP-compliant sterile manufacturing controls govern the production environment throughout.

Product details

Brand	Kim Pharma
Active ingredient	stanozolol injection
Strength	50 mg
Form	Vial
Pack size	1 piece
Item number	INJ-STAN-KIM-50-021

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Strombaject 50mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Strombaject 50mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Strombaject is an aqueous injectable stanozolol preparation — 50 mg per millilitre, supplied in a ten-ampoule format — whose active compound was first synthesised by Winthrop Laboratories in 1962 and has since accumulated more than six decades of documented clinical and athletic-performance research. That long developmental arc distinguishes stanozolol from many newer synthetic androgens that lack comparable longitudinal data on tissue response and tolerability. Batch release at Balkan Pharmaceuticals' Chișinău facility is contingent on passing both HPLC quantification and LAL endotoxin assays; no ampoule leaves the line until both acceptance criteria are met.

€42.00

Stanobolin-50 50mg/ml 10x1ml Ampoules by BM Pharmaceuticals

High Concentration

Stanobolin-50 50mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Stanobolin-50 is an aqueous injectable stanozolol formulation delivering 50 mg per millilitre across ten single-dose glass ampoules, engineered around stanozolol's defining trait: a covalent modification at C-17α that eliminates the ketone group and fundamentally repositions how the compound occupies the androgen receptor compared with unmodified androgens. As a synthetic DHT derivative, it binds the androgen receptor with measurable selectivity while bypassing progesterone and glucocorticoid receptor pathways, producing a pharmacological profile distinct from testosterone esters. Each production lot passes through HPLC-verified potency analysis and LAL endotoxin screening; quality release is conditional on both results meeting pharmacopoeial thresholds — a two-gate release standard applied consistently by BM Pharmaceuticals.

€42.00

Long-Acting Formula

StanoTrex 150mg/ml 10ml Vial by Concentrex Labs

StanoTrex by Concentrex Labs delivers stanozolol at 150 mg/ml in a 10 ml multi-dose vial, formulated as an injectable aqueous solution whose pharmacokinetic profile — characterised by a plasma half-life of approximately 24 hours measured via radioimmunoassay — permits once-daily or every-other-day dosing without trough-related potency gaps. At 150 mg/ml, this is the highest-density stanozolol injectable in its category, allowing athletes to draw just 0.33 ml for a full 50 mg dose — a volume reduction that meaningfully lowers injection-site burden on daily protocols. Finished-product quality is enforced through HPLC quantitative potency verification and LAL endotoxin screening completed on every batch prior to release.

€44.00

Winstrol Depot 50mg/ml 3x1ml Ampoules by Desma

GMP Standard

Winstrol Depot 50mg/ml 3x1ml Ampullen by Desma

Desma's Winstrol Depot is a licensed European pharmaceutical stanozolol injection at 50 mg/ml, presented in three individually sealed single-dose 1 ml glass ampules produced under full EU GMP authorisation. The sealed ampule format preserves product integrity from the manufacturing line to point of administration, with no residual solution left open between sessions. Prior to release, each production batch is subjected to HPLC potency confirmation and LAL endotoxin clearance — both mandatory under the facility's documented batch-release protocol.

€4.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00